Urinary tract infections, central line-associated bloodstream infections, and ventilator-associated pneumonia are among the healthcare-associated infections. Catheter-associated urinary tract infection (CAUTI) is caused by urinary catheters that are placed to drain urine from the bladder. CAUTI is one of the most common infections among UTIs acquired in the hospital. As per the Centers for Disease Control and Prevention (CDC) report published in 2020, approximately 75% of infections are associated with a urinary catheter during hospital stays. Prolonged discomfort, longer hospital stays, increased treatment expenses, and even mortalities are the complications associated with CAUTI. As per CDC, nearly 13,000 deaths annually are associated with UTIs. Thus, the increasing incidence of CAUTI stokes the demand for coated medical devices, thereby driving the North America medical device coating market.
The North America medical device coating market is segmented into the US, Canada, and Mexico. This is attributed to favorable healthcare resources and a rise in the frequency of cardiometabolic disorders such as pulmonary embolism (PE) and deep vein thrombosis (DVT), resulting in the adoption of medical device coating. Also, increase in COVID-19 cases, high adoption of advanced surgical treatments, and rise in healthcare infrastructure in the US are expected to boost the demand for medical device coating in the coming years. The US remains the largest medical device market globally, owing to the presence of more than 6,500 medical device companies comprising small and medium-sized enterprises (SMEs). The states in the US comprising the highest number of medical device companies involve California, Florida, New York, Pennsylvania, Michigan, Massachusetts, Illinois, Minnesota, and Georgia. Additionally, US medical device companies are highly recognized worldwide due to their innovative and high-technology products.
The North America medical device coating market is segmented into material type, devices, coating, application, and country. Based on material type, the market is segmented into polymers, metals, and others. The metals segment registered the largest market share in 2022.
Based on devices, the North America medical device coating market is segmented into medical equipment and tools, medical devices, medical implants, and others. The medical devices segment registered the largest market share in 2022.
Based on coating, the North America medical device coating market is segmented into hydrophilic coatings, anti-microbial coatings, drug-eluting coatings, anti-thrombogenic coatings, and others. The hydrophilic coatings segment registered the largest market share in 2022.
Based on application, the North America medical device coating market is segmented into infectious diseases, neurology, orthopedics, general surgery, and others. The others segment registered the largest market share in 2022.
Based on country, the market is segmented into the US, Canada, and Mexico. The US dominated the market share in 2022.
AST Products Inc, Biocoat Inc, Covalon Technologies Ltd, Formacoat LLC, Harland Medical Systems Inc, Hydromer Inc, Kisco Ltd, Koninklijke DSM NV, Precision Coating Company Inc, and Surmodics Inc are among the leading companies operating in the medical device coating market in the region.